GB1491358A - Pharmaceutical materials - Google Patents

Pharmaceutical materials

Info

Publication number
GB1491358A
GB1491358A GB2711175A GB2711175A GB1491358A GB 1491358 A GB1491358 A GB 1491358A GB 2711175 A GB2711175 A GB 2711175A GB 2711175 A GB2711175 A GB 2711175A GB 1491358 A GB1491358 A GB 1491358A
Authority
GB
United Kingdom
Prior art keywords
june
pharmaceutical materials
acylating
pharmaceutical
sarcomainhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2711175A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to GB2711175A priority Critical patent/GB1491358A/en
Publication of GB1491358A publication Critical patent/GB1491358A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)

Abstract

1491358 Berbine derivatives KANEBO Ltd 4 June 1976 [26 June 1975] 27111/75 Heading C2C Novel compounds I in which R 1 and R 2 are methoxy or together form a methylenedioxy group, R 3 is methyl, 4-methoxyphenyl or 2-phenylvinyl and X is a pharmaceutically acceptable anion, are prepared by acylating 13-methylberberrubine or 13- methylpalmatrubine with an appropriate acylating agent. Pharmaceutical compositions having sarcomainhibiting activity, for oral or parenteral administration, comprise one of the above compounds together with a pharmaceutical carrier.
GB2711175A 1976-06-04 1976-06-04 Pharmaceutical materials Expired GB1491358A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2711175A GB1491358A (en) 1976-06-04 1976-06-04 Pharmaceutical materials

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2711175A GB1491358A (en) 1976-06-04 1976-06-04 Pharmaceutical materials

Publications (1)

Publication Number Publication Date
GB1491358A true GB1491358A (en) 1977-11-09

Family

ID=10254378

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2711175A Expired GB1491358A (en) 1976-06-04 1976-06-04 Pharmaceutical materials

Country Status (1)

Country Link
GB (1) GB1491358A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184118A1 (en) * 1984-11-29 1986-06-11 Ss Pharmaceutical Co., Ltd. 13-propylberberine salts

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184118A1 (en) * 1984-11-29 1986-06-11 Ss Pharmaceutical Co., Ltd. 13-propylberberine salts
US4761477A (en) * 1984-11-29 1988-08-02 Ss Pharmaceutical Co., Ltd. 13-propylberberine salts

Similar Documents

Publication Publication Date Title
GB1505305A (en) Benzcycloamide derivatives
NL194821B (en) Pharmacologically active catechol derivatives and their compositions.
AU4690379A (en) Administering intravenous drugs
FR2567885B1 (en) 3-AMINOPROPOXYARYL DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FI873465A0 (en) COMPOSITION FOR PARENTERAL ADMINISTRATION AND DEVELOPMENT OF DESC.
FI860923A0 (en) I HAVE A DISPENSER AND A POLYMER COMPOSITION FOR PARENTERAL ADMINISTRATION.
IE34583L (en) Esters of hydroxyphenylalkanolamines
ES457417A1 (en) Hypotensive 3,4-dihydro-2,2-dimethyl-4-amino-2H-benzo[b]pyran-3-ols
GB1205957A (en) Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes
IT8922693A0 (en) SEMI-SYNTHETIC DERIVATIVES WITH IMMUNOMODULANT ACTIVITY SUITABLE FOR PARENTERAL AND ORAL ADMINISTRATION
PH24239A (en) New 4-pyridone derivatives,their pharmaceutical compositions and use
AU1518492A (en) Pharmaceutical compositions for transcutaneous administration
IE38979L (en) Tetrazolyl - quinoxalinecarboxamide derivatives
GB1268951A (en) Phenoxy-amines
GB1188846A (en) Thiazole Derivatives
IT8121654A0 (en) THIAZOLIDINE DERIVATIVES WITH PHARMACOLOGICAL ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES.
GB1491358A (en) Pharmaceutical materials
IL76345A0 (en) Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same
GB1216295A (en) New enzyme inhibitors and their preparation
DE2860248D1 (en) New cephalosporin derivatives, their preparations and their pharmaceutical compositions
GB1518621A (en) Analgesic composition
GB1449404A (en) N-arylsulphonyl urea derivatives
GB1531781A (en) N-propargyl-piperonylamine and its preparation and use
GB1468079A (en) Ethanolamine derivatives
KR900700471A (en) New 2,3-thiomorpholine dione-2-oxime derivatives, pharmaceutical compositions and preparations containing them

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee